Feed excerpt — reported by STAT News
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →